Recognising the medical sector’s uncompromising expectations around cleanliness, precision, and complete process control, the Changzhou facility has invested over €250,000 in new technologies designed to elevate quality assurance and reinforce Lesjöfors’ long-term commitment to the medical market.
A first-of-its-kind cleanroom capability for Lesjöfors
At the heart of the investment in Changzhou is a new automated hydrocarbon-based cleaning system, installed directly within the cleanroom environment – the first installation of its kind across Lesjöfors’ global medical manufacturing operations.
Delivering enhanced cleanliness standards, the new system ensures consistent, high-quality cleaning of stamped and deep-drawn parts.
Critical accuracy, quality enhancement & full traceability
Lesjöfors China has also strengthened its quality assurance framework with a series of precision-focused investments, including a new coordinate measuring machine (CMM) – enabling highly accurate dimensional verification.
This is complemented by a fully integrated traceability system, ensuring every production batch can be tracked seamlessly. Reinforcing product integrity, the site has also implemented 100% CCD inspection, using advanced imaging technology to automatically assess every part and prevent any non-conforming components from reaching the customer.
Medical sector commitment
Mikael Anderson, VP of Business Region Asia concludes: “These investments are far more than a local investment – it’s a milestone in our global medical strategy. Across Europe, the Americas, and Asia, we are building a unified network of capabilities that meet the highest medical manufacturing standards. With China now introducing our first cleanroom-based cleaning technology, we are reinforcing a commitment to deliver precision, cleanliness and traceability at a truly international scale.”